Skip to content

Clinical research of WeiRen XiaoYou recipe (TongYouJin) in the treatment of palmoplantar warts

Clinical research of WeiRenXiaoYou recipe (TongYouJin) in the treatment of palmoplantar warts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005810
Enrollment
Unknown
Registered
2022-04-04
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

palmoplantar warts

Interventions

experimental group:WeiRenXiaoYou recipe
Control group:Salicylic acid ointment

Sponsors

Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) the patient should meet the diagnostic criteria of multiple palmoplantar warts, and the skin lesions are located in the fingers and toes; (2) the age of the patient should be greater than or equal to 18 years old, less than or equal to 70 years old, regardless of gender; (3) the patient has not received treatment for the disease within at least one month before entering the group; (4) the patient / legal guardian agrees to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) those who are allergic to any one of the ingredients of traditional Chinese medicine; (2) those who are allergic to salicylic acid ointment; (3) patients with severe hypertension or severe heart failure, liver, kidney, acquired immunodeficiency syndrome and other diseases; (4) patients with immunosuppression, or long-term use of corticosteroids; (5) patients who participated or are participating in other clinical studies or clinical trials 1 month ago. (6) pregnant and lactating women; (7) patients with skin lesions have shown a significant tendency of self-healing; (8) researchers think that it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Pain level;Number of warts;Diameter of warts.;

Secondary

MeasureTime frame
Dermatology Life Quality Score;Relapse rate;

Countries

China

Contacts

Public ContactGuo Dongjie

Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital

gdongjie.1992@163.com18121205221

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026